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Abstract
Colorectal cancer (CRC) is the third most common cancer
and second leading cause of cancer-related death in the
United States. Colonoscopy is widely preferred for CRC
screening and is the most commonly used method in the
United States. Adequate bowel preparation is essential
for successful colonoscopy CRC screening. However,
up to one-quarter of colonoscopies are associated with
inadequate bowel preparation, which may result in re
duced polyp and adenoma detection rates, unsuccessful
screens, and an increased likelihood of repeat procedure.
In addition, standardized criteria and assessment scales
for bowel preparation quality are lacking. While several
bowel preparation quality scales are referred to in the
literature, these differ greatly in grading methodology and
categorization criteria. Published reliability and validity
data are available for five bowel preparation quality
assessment scales, which vary in several key attributes.
However, clinicians and researchers continue to use a
variety of bowel preparation quality measures, including
nonvalidated scales, leading to potential confusion and
difficulty when comparing quality results among clinicians
and across clinical trials. Optimal clinical criteria for bowel
preparation quality remain controversial. The use of
validated bowel preparation quality scales with stringent
but simple scoring criteria would help clarify clinical trial
data as well as the performance of colonoscopy in clinical
practice related to quality measurements.
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preparation (excellent/good/fair); this relationship was
weaker but still significant for advanced adenomas
[17]
(OR = 0.74, CI: 0.62-0.87; P < 0.001) . Other
studies have reported overall adenoma miss rates
of 42%-48% for initial colonoscopies with inadequate
or low-quality bowel preparation, based on findings at
[13,18]
repeat colonoscopies
. Inadequate bowel preparation
for colonoscopy may also result in prolonged procedures,
more frequent repeat colonoscopies (at shorter
than recommended intervals) and related increased
costs, lower cecal intubation rates, and higher risk of
[6,11,19-21]
electrocautery
. Studies in various international
populations have found that inadequate cleansing is
a factor in approximately 20%-70% of incomplete
[22-25]
colonoscopies
. Professional gastroenterology
societies recommend that clinical practices aim for mini
mum adequate bowel preparation rates of 85%-90%,
and that bowel preparation quality be documented at the
[6,26]
time of the screening
.
Currently, no standard criteria or definition exists
for qualitative terms such as “adequate”, “inadequate”,
“excellent”, “good”, “fair”, or “poor”; in some scales,
adequate cleansing is defined as a composite of “good”
[11,26]
and “excellent”
. Physician reporting on quality of
bowel preparation, as well as overall colonoscopy quality,
is highly inconsistent and often missing important ele
ments, which may be attributable to lack of clear and
[27]
consistent quality assessment standards . Therefore,
this review was conducted to summarize and discuss
currently available bowel preparation quality scales and
highlight the benefits of using a reliable and validated
scale in both clinical practice and clinical trials of bowel
preparation agents.

Core tip: Adequate bowel preparation is essential for
proper visualization of the colonic mucosa to optimize
lesion detection for a successful colonoscopy. Clinicians
and researchers continue to use a variety of bowel prep
aration quality measures, including de novo , nonvalidated
scales in clinical studies, leading to potential confusion,
and creating difficulty when comparing bowel preparation
quality results across clinical trials. Based on data eval
uating different bowel preparation quality scales in the
literature, and published criteria that define the most
desirable measures to be used in such grading scales, the
Boston Bowel Preparation Scale is currently recommended
as standard.
Kastenberg D, Bertiger G, Brogadir S. Bowel preparation
quality scales for colonoscopy. World J Gastroenterol 2018;
24(26): 2833-2843 Available from: URL: http://www.wjgnet.
com/1007-9327/full/v24/i26/2833.htm DOI: http://dx.doi.
org/10.3748/wjg.v24.i26.2833

INTRODUCTION
Colorectal cancer (CRC) is the third most common
cancer, with an estimated risk of occurring in 1 of 18
persons during their lifetime, and is the second most
common cause of cancer-related adult deaths in the
[1,2]
United States . Approximately 135000 new CRC cases
and 50000 CRC deaths were projected to occur in 2017
[1]
in the United States . For average risk individuals,
the United States Preventive Services Task Force and
other public health and professional medical bodies
recommend CRC screening using colonoscopy, com
puterized tomography colonography, sigmoidoscopy,
double-contrast barium enema, high-sensitivity guaiac or
immunochemical fecal occult blood testing, or stool DNA
testing (which is combined with immunochemical blood
[2-4]
testing) beginning at the age of 50 years . Colono
scopy is a preferred and the most widely used method
[4-6]
for CRC screening in the United States , based on data
showing this procedure is correlated with decreased CRC
incidence and deaths, most likely through the detection
[7-10]
and removal of premalignant polyps
.
Adequate bowel preparation is essential to ensure
sufficient visualization of the colonic mucosa and to
optimize lesion detection for successful colonoscopy
[4,11]
utilized for CRC screening
. However, study data
indicate that up to one-quarter of colonoscopies may
[12,13]
be conducted with inadequate bowel preparation
,
which is correlated with lower detection of polyps and
adenomas vs adequate preparation (typically good/
[12,14-16]
excellent quality)
. A meta-analysis of 27 studies
found that inadequate bowel preparation for colonoscopy
CRC screening reduced detection of small adenomas by
47% (OR = 0.53, CI: 0.46-0.62; P < 0.001) vs adequate

WJG|www.wjgnet.com

COMPONENTS OF A BOWEL
PREPARATION QUALITY SCALE
Essential attributes of a dependable bowel preparation
[11]
quality scale include reliability and validity . Scale
reliability involves the degree to which an instrument
yields reproducible, or consistent, results for the same
investigator (intrarater reliability) or among different
investigators (interrater reliability), upon repeated
[11,28]
testing
. Validity indicates how well the scale mea
sures what it is designed to assess, which can be
[29]
determined via several methods . Validity may be as
sessed by comparison with results of other established
and accepted scales used for the same purpose (i.e.,
bowel preparation quality) in the same test population,
referred to as construct validity. Scale validity may also
be assessed by correlation with other specific criteria
measuring relevant clinical outcomes, in this case, overall
colonoscopy quality; this is referred to as criterion-related
[29,30]
validity or predictive validity
.
A commonly used criterion for overall quality of CRC
screening colonoscopy is the adenoma detection rate
(ADR), defined as the proportion of all CRC screening
colonoscopies performed by a physician that reveal

2834
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[6,31]

at least one adenoma
. Studies have shown that
colonoscopy ADR is strongly, inversely associated with
reduced interval CRC rates (CRC diagnosed between
the time of screening colonoscopy and the scheduled
time of surveillance colonoscopy, which was up to 10
[32,33]
years)
, and that increasing ADRs are correlated
[34]
with reduced CRC incidence and mortality . Some
data also indicate that the polyp detection rate (PDR),
the number of patients with at least one polyp removed
during screening CRC, may also be a useful parameter
of colonoscopy quality, particularly since it appears to
[6]
correlate well with ADR . However, use of the PDR raises
additional questions related to the precise definition of
“polyp”. Other questions include whether the detection
rates of sessile serrated polyps (SSPs), advanced
adenomas, and multiple adenomas (as opposed to a “one
and done” approach) should be used as key indicators
[6]
of colonoscopy quality in addition to the ADR and PDR .
However, clinical data are insufficient for resolution
of these issues, and no guidelines for correlation of
bowel preparation quality with detection rates for SSPs,
advanced adenomas, and multiple adenomas have yet
[6]
been established . Thus, ADR appears to be the best
criterion currently available, as it is relatively easy to
measure and has been shown to correlate with interval
cancer rate.
The cecal intubation rate, an indicator of colonoscopy
completion (reaching the cecum or anastomosis, if
[6,21,26]
present), is another acknowledged quality measure
.
Cecal intubation is essential for visualization of the proxi
mal colon, including the caecum, where many colorectal
[6]
neoplasms are located, in particular SSPs . However,
data on the independent association of cecal intubation
[32,35]
rate with CRC risk have been mixed
. Longer with
drawal time is associated with higher ADR and higher
SSP detection and is also considered a key criterion of
[6,36-38]
colonoscopy quality secondary to ADR
.
Another recommended criterion of colonoscopy
quality is the level of adherence to recommended postpolypectomy and post-cancer surveillance intervals, which
[2,6,39,40]
are based on study data
. The United States MultiSociety Task Force on Colorectal Cancer (USMSTFCC) has
recommended that this criterion may serve as the overall
[11]
indication of clinical adequacy of a bowel preparation .
Intra-procedure flushing and suctioning to remove
fluid and semisolid debris is often performed during
[11]
colonoscopy . Therefore, the USMSTFCC recommends
that bowel preparation quality should be assessed on
[11]
withdrawal after washing and suctioning . This criterion
relates primarily to clinical adequacy, where washing and
suctioning is taken into account, and is less relevant for
the comparison of different bowel preparation agents,
where pre-wash grading of bowel cleanse quality may
better reflect preparation agent efficacy.

bowel preparation quality scales in clinical trials include
[41,42]
the Aronchick Scale
, the Boston Bowel Preparation
[43-49]
Scale (BBPS)
, and the Ottawa Bowel Preparation
[50]
Scale (OBPS) (Table 1). Other instruments that have
been validated, but are less commonly used, include
[51]
the Harefield Cleansing Scale (HCS) and the Chicago
[52]
Bowel Preparation Scale (CBPS) (Table 1). A summary
of validation studies is found in Table 2.

Aronchick scale

The Aronchick Scale was the first bowel preparation
[41,42]
quality scale to be evaluated for reliability
. This
scale characterizes the percentage of the total colonic
mucosal surface covered by fluid or stool, without scoring
for separate colon segments, and is performed before
washing or suctioning (Table 1). A validity study found
that interobserver reliability kappa intraclass correlation
coefficients (ICCs) were high for the cecum (0.76) and
the total colon (0.77), but were reduced for the distal
[42]
colon (0.31) and ascending colon segments . The Aron
chick Scale is one of the most commonly used validated
bowel preparation quality scales in clinical trials and
clinical practice.

Ottawa Bowel Preparation Scale

The OBPS measures mucosal cleanliness by colon seg
ment, including the right colon, mid-colon, and recto
sigmoid colon, on a scale of 0 (excellent) to 4 (inadequate)
for each (Table 1 and Figure 1), and is also scored
[50]
before washing or suctioning . However, in contrast to
the Aronchick scale, the OBPS measures fluid quantity
separately, with scores ranging from 0 (small volume)
to 2 (large volume) for the total colon. Additionally, the
OBPS does not tie scoring to subjective estimates of
the percentage of the mucosa that is visible, which the
investigators suggested might improve interobserver
[50]
reliability (Table 1) . In a study of reliability and
validity compared with the Aronchick scale, the Pearson
correlation coefficients for interobserver ratings were
superior for the OBPS vs the Aronchick (0.89 vs 0.62,
[50]
respectively; P < 0.001) . Similarly, the kappa ICCs
also significantly favored the OBPS vs the Aronchick scale
[0.94 (95%CI: 0.91-0.96) vs 0.77 (95%CI: 0.65-0.84),
respectively; P < 0.001]. Interrater consistency was
found to be stronger with the OBPS vs the Aronchick
scale, and reliability and agreement of the OBPS for the
three different colon segments measured were very high,
and not significantly different between segments (0.92
kappa, right colon; 0.88 kappa, mid-colon; 0.89 kappa,
rectosigmoid; 0.94 kappa, total colon).
A prospective study of the OBPS aimed to identify an
optimal cut-off score for bowel preparation adequacy/
inadequacy in 211 patients undergoing colonoscopy at
[53]
a single center . The receiver operating characteristic
(ROC) analysis used in this study found that an OBPS
score cutoff of ≥ 8 identified inadequate bowel prep
aration with a sensitivity of 100% and a specificity
of 91%. Another study in 150 consecutive patients
undergoing colonoscopy reported strong concordance

VALIDATED BOWEL PREPARATION
SCALES
The most well established and commonly used validated

WJG|www.wjgnet.com
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Table 1 Validated bowel preparation scales
Scale name

Score

Aronchick Scale

1
2
3
4

Ottawa Bowel
Preparation Scale
(by colon segment)

5
0

1

2

3

4
Ottawa Bowel
Preparation Scale
(total colon fluid)

0
1
2

Boston Bowel
Preparation Scale
(by colon segment)

0
1

2

3

Harefield Cleansing
Scale (by colon
segment)

0
1
2
3
4

Rating/description

Other scale properties/characteristics

Excellent: Small volume of liquid; > 95% of mucosa
Total score range: Minimum 1 (excellent) to maximum 5
seen
(inadequate)
Good: Clear liquid covering 5%-25% of mucosa, but
Scoring performed before washing or suctioning
> 90% of mucosa seen
No separate ratings for segments; global colon rating only
Fair: Semisolid stool could not be suctioned or
No threshold for adequate/inadequate provided
washed away, but > 90% of mucosa seen
Poor: Semisolid stool could not be suctioned or
washed away and < 90% of mucosa seen
Inadequate: Repeat preparation/screening needed
Excellent: Mucosal detail clearly visible, almost no
Total score (obtained by adding scores for each segment + total
stool residue; if fluid present, it is clear, almost no
colon fluid score) range: Minimum 0 (excellent) to maximum 14
stool residue
(inadequate)
Good: Some turbid fluid or stool residue, but
Scoring performed before washing or suctioning
mucosal detail still visible without need for
Rates cleansing by colon segment: Right colon, mid-colon, and
washing/suctioning
rectosigmoid colon (Figure 1)
Fair: Some turbid fluid of stool residue obscuring
No threshold for adequate/inadequate provided
mucosal detail; however, mucosal detail becomes
visible with suctioning, washing not needed
Poor: Stool present obscuring mucosal detail
and contour; a reasonable view is obtained with
suctioning and washing
Inadequate: Solid stool obscuring mucosal detail
and not cleared with washing and suctioning
Small amount of fluid
Total colon fluid score range: Minimum 0 (small amount of fluid)
Moderate amount of fluid
to maximum 2 (large amount of fluid)
Large amount of fluid
Scoring performed before washing or suctioning
Single score for the total colon
No threshold for adequate/inadequate provided
Unprepared colon segment with mucosa not seen
Total score (obtained by adding scores for each segment) range:
because of solid stool that cannot be cleared
Minimum 0 (very poor) to maximum 9 (excellent)
Portion of mucosa of the colon segment seen, but
Scoring performed after washing or suctioning
other areas of segment not well seen because of
Segments separately rated: Right colon (including cecum and
staining, residual stool, and/or opaque liquid
ascending colon); transverse (includes hepatic and splenic
Minor amount of residual staining, small fragments
flexures); and left colon (descending and sigmoid colon, and
of stool, and/or opaque liquid, but mucosa of colon
rectum)
segment is well seen
Threshold optimally is total score of ≥ 6 AND ≥ 2 per segment
Entire mucosa of colon segment well seen, with
no residual staining, small fragments of stool, or
opaque liquid
Irremovable, heavy, hard stools
Total score (obtained by adding scores for each segment) range:
Semisolid, only partially removable stools
Minimum 0 (very bad) to maximum 20 (very good)
Brown liquid/fully removable semi-solid stools
Scoring performed after washing or suctioning
Clear liquid
Segments separately rated: Rectum, sigmoid, left, transverse,
Empty and clean
right colon
Threshold for successful cleansing = Grade A: no segment scored
< 3 or 4, or Grade B: ≥ 1 segment scored 2 but no segment < 2;
Unsuccessful cleansing = Grade C: ≥ 1 segment scored 1 but no

Chicago Bowel
Preparation Scale
(by colon segment)

0
5

10
11
12
Chicago Bowel
Preparation Scale
(total colon)

0
1
2
3

Unprepared colon segment with stool that cannot be
cleared (> 15% of mucosa not seen)
Portion of mucosa in segment seen after cleaning,
but up to 15% of the mucosa not seen because of
retained material
Minor residual material after cleaning, but mucosa
of segment generally well seen
Entire mucosa of segment well seen after washing
Entire mucosa of segment well seen before washing
or suctioning
Little fluid (≤ 50 cc)
Minimal amount of fluid (51-150 cc)
Moderate amount of fluid (151-300 cc)
Large amount of fluid (> 300 cc)

WJG|www.wjgnet.com
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segment < 1, or Grade D: ≥ 1 segment scored 0
Total score (obtained by adding scores for each segment) range:
Minimum 0 (unprepared) to maximum 36 (excellent)
Scoring performed before (fluid) and after (mucosal cleaning)
washing or suctioning
Segments separately rated: Right (cecum to mid-hepatic flexure),
transverse (mid-hepatic flexure to mid-splenic flexure), and left
colon (mid-splenic flexure to distal rectum)
No threshold for adequate/inadequate provided

Total score range: Minimum 0 (little fluid) to maximum 3 (large
amount of fluid)
Scoring performed before washing or suctioning
No threshold for adequate/inadequate provided
Not incorporated into total score for segments
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Table 2 Reliability and validation data for bowel preparation scales
Scale
Aronchick

OBPS

BBPS

Study

Colons
(n )

Raters
(n )

Aronchick[41],
2004

80

5

Rostom
et al[50], 2004

97

2

Chan
et al[53], 2011

211

NR

Martinato
et al[54], 2013
Lee
et al[58], 2016

150

NR

655

NA

Lai
et al[47], 2009

633

22

Reliability

Validity

ICC values for:
Total colon: 0.77
Cecum: 0.76
Distal colon: 0.31
ICC values for:
Right colon: 0.92
Mid colon: 0.88
Rectosigmoid colon: 0.89
NR

Ratings of physicians vs nurses:
PCC: r = 0.60
NR

ICC values:
0.74/0.77 wtd κ

NR

Comparisons with Aronchick scale
PCC: 0.89 OBPS vs 0.62 Aronchick
ICC: 0.94 OBPS vs 0.77 Aronchick
Cutoff scores for adequacy/inadequacy
Optimal cutoff for inadequate ≥ 8: Sensitivity, 100%, specificity,
91%
Correlations with VAS
PCC (physicians vs nurses): r = 0.60
Comparison with BBPS for PDR and ADR
PCC: r = -0.62 (P < 0.001); AUC of ROC analysis similar for PDR,
ADR, right-sided adenomas, and SSAs
PDR by score
40% for scores ≥ 5 vs 24% for scores < 5 (P < 0.02)
Need for repeat CSP due to inadequate bowel prep
2% for scores ≥ 5 vs 73% for scores < 5 (P < 0.001)

Calderwood
et al[43], 2010

119

12

ICC values for:
Total colon: 0.91
Right colon: 0.88
Transverse colon: 0.83
Left colon: 0.79

Correlation with colonoscope insertion time
PCC: r = -0.16 (P < 0.003)
Correlation with colonoscope withdrawal time
PCC: r = -0.23 (P < 0.001)
Correlations with ability to exclude polyps > 5 mm
100%, 88%, 82%, 33%, and 0% of physicians deemed bowel
preparation adequate to exclude polyps > 5 mm at scores of ≥ 8, 7, 6,
5, and ≤ 4 respectively
Correlations with surveillance recommendations after normal CSP
Score < 5: 100% recommended ≤ 1 yr
Scores 5-6: mean recommended interval 4.3 (± 3.9) yr
Scores ≥ 7: 100% recommended 10 yr
Physician-recommended CSP interval after negative CSP
Scores ≥ 6 (≥ 2 each segment): 90% recommended 10 yr

Calderwood
et al[44], 2014

2516

74

NR

Schindler
et al[49], 2016
Gao
et al[45], 2013
Kim
et al[46], 2014

3

401

1012

13

482

6

ICC values, all raters (all segment
and total scores): 0.93
ICC values:
0.987/0.671 wtd κ
ICC values:
Total colon: 0.90/0.63 wtd κ
Right colon: 0.93/0.91 wtd κ
Transverse colon: 0.88/0.86 wtd κ
Left colon: 0.50/0.38 wtd κ

HCS

CBPS

Clark
et al[57], 2016

438

4

ICC values by BBPS scores:
0 and 3: 1.0
2: 0.81
1: 0.80

Halphen
et al[51], 2013

337

4

ICC value:
0.457
Test-retest κ values:

Gerard
et al[52], 2013

150

44

Range, 0.33 to 0.85
Intrarater2:
0.28 to 0.64
Internal consistency3:
0.81, 0.86
ICC values for:
Range, 0.624 to 0.702 for all
segments

Scores 0-2: 96% recommended ≤ 1 yr
NR
PDR
Scores ≥ 5 superior vs < 5 (35% vs 18%; P < 0.05)
PDR
Scores ≥ 8 superior vs scores < 8 (44.9% vs 33.0%; P = 0.04)
Colonoscope withdrawal time
PCC: r = -0.167 (P < 0.001)
Colonoscope insertion time
PCC: r = 0.018 (P = 0.695)
ADR (> 5 mm) miss rates by BBPS score:
3: 5.6%
2: 5.2%
1: 15.9%
Score of 2 noninferior to 3 for missed adenoma > 5 mm
Best score cutoff for satisfactory bowel preparation
≥ 2 for each segment: Sensitivity, 99% and specificity, 83%
Correlation with Aronchick scale
PCC: r = 0.833
AUC of ROC analysis (vs Aronchick scale scores)
0.945 for total colon

Correlations of scores with adequate cleansing
Adequate: Scores of 25-36 (≥ 95% of mucosa visualized)
Inadequate: Scores of 0-24 (< 95% of mucosa visualized)

1

Raters included endoscopy nurses (n = 17), gastroenterology faculty (n = 14), and gastroenterology fellows (n = 9); 2Generalized κ for global agreement;
Cronbach’s alpha; 4Raters included three gastroenterologists and one physician’s assistant. ADR: Adenoma detection rate; AUC: Area under the curve;
BBPS: Boston Bowel Preparation Scale; CBPS: Chicago Bowel Preparation Scale; CSP: Colonoscopy; HCS: Harefield Cleansing Scale; ICC: Interobserver
reliability kappa intraclass correlation coefficient; NA: Not applicable; NR: Not reported; OBPS: Ottawa Bowel Preparation Scale; PCC: Pearson correlation
coefficient; PDR: Polyp detection rate; ROC: Receiver operating characteristic; SSA: Sessile serrated adenoma; VAS: Visual analogue scale; wtd: Weighted.
3
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to inadequate bowel preparation was significantly higher
in patients with scores < 5 vs those with scores ≥ 5
(73% vs 2% of cases, respectively; P < 0.001). Total
BBPS scores were inversely associated with colonoscopic
insertion (r = -0.16; P < 0.003) and withdrawal times
(r = -0.23; P < 0.001). In addition, a significant trend
in mean BBPS score correlating with excellent, good,
fair, poor, or unsatisfactory, as separately scored by the
raters, was observed (P < 0.001 for trend).
A follow-up study investigated interobserver reliability
and clinical outcome correlations of BBPS scores for
individual segments, and relationship of scores to polyp
detection in 119 screening colonoscopies rated by nine
[43]
full-time faculty and three fellows at a single center . All
(100%) raters judged the bowel preparation adequate to
exclude polyps > 5 mm with a ≥ 8 BBPS score, vs 88%
of physicians when the score was 7, 82% when the score
was 6, 33% when the score was 5, and 0% with a score
of ≤ 4. Thus, a score of ≥ 6 was a particularly important
threshold, since approximately 80% of physicians found
the bowel preparation adequate at that score vs only
one-third or less at BBPS scores of ≤ 5. In patients who
had undergone a normal screening colonoscopy, a score
of < 5 prompted all physicians to recommend repeat
colonoscopy within one year, while a score of ≥ 7 was
correlated with a recommendation for the next colonoscopy
to occur in 10 years (among all physicians). BBPS segment
scores were positively correlated with improved PDRs for
the left and right colon, but no association was found for the
transverse colon.
A further validation study was aimed at identifying
a cut-off score for adequacy/inadequacy of bowel prep
[44]
aration . This retrospective study of 2516 normal CRC
screening colonoscopies performed by 74 endoscopists
found that follow-up was recommended in 10 years
for 90% of cases with a total BBPS score ≥ 6 in which
all three segments had scores ≥ 2 (n = 2295), while
96% of examinations with total BBPS scores of 0-2 (n
= 26) recommended follow-up within one year (Figure
2). Screenings with total scores of 3-5 (n = 167) had
variable recommendations. Based on these findings,
the investigators suggested that a total BBPS score
of ≥ 6 and/or all segment scores ≥ 2 may serve as a
[44]
standard definition of “adequate for 10-year follow-up” .
However, a prospective, observational study in a large,
national endoscopic consortium found that inadequate
single BBPS segment scores at the initial, average-risk
screening colonoscopy were correlated with significantly
greater risk of polyps at a second colonoscopy, sug
gesting that both a total score of ≥ 6 and all segment
scores ≥ 2 should be required as an adequacy standard
[56]
for 10-year follow-up . This assessment was affirmed
by a study in 438 colonoscopies in men, which found that
BBPS segment scores of 2 or 3 (with 2 being noninferior
to 3) was indicative of adequate bowel preparation for
detection of adenomas > 5 mm, and for repeat colo
noscopy at standard, guideline-recommended intervals
(both parameters are USMSTFCC-recommended criteria
[11,57]
for bowel preparation adequacy)
.

Mid

Right

Rectosigmoid

Figure 1 Bowel preparation quality scale segments. Depiction of bowel
segments from validation study of Ottawa Bowel Preparation Scale[50]. Before
washing or suctioning, each segment is scored on a scale of 0-4 for cleansing,
and the total colon is scored for fluid quantity on a scale of 0-2. The total score
ranges from 0 (excellent) to 14 (inadequate).

between the OBPS and a visual analogue scale mea
suring bowel cleansing among both nurses (r = 0.8268)
[54]
and physicians (r = 0.8095), P < 0.0001 for both . The
concordance in scoring between nurses and physicians
was r = 0.6010; P < 0.0001.

Boston Bowel Preparation Scale

The BBPS has been validated in multiple clinical stud
[11,47,55]
ies
. Developed in 2009, this scale was designed
to address specific issues affecting bowel preparation
quality and scoring: (1) The scale stipulates that scoring
is to be conducted upon withdrawal and after all flushing
and suctioning of fluid have been completed; (2) scoring
is applied by colon segments, as in the OBPS, based
on potential for variance in bowel preparation between
segments; and (3) subjective, qualitative terms, such as
excellent, good, fair, or poor, are replaced by numbered
scores that are correlated to more clearly described colo
nic conditions, including features such as staining, liquid,
[47]
and stool fragments (Table 1) . Each segment of the
colon is scored from 0 to 3, with higher scores indicating
superior cleansing, and summed for a total score that
can range from 0 to 9 (Table 1).
The initial validation study for the BBPS involved
633 CRC screening colonoscopies in a single center,
and was applied by endoscopists who had undergone
training on how to use the scale before participating in
[47]
the study . The median BBPS total score was 6. The
ICC for interobserver agreement of total BBPS scores
was 0.74 (95% predictive interval: 0.67-0.80), and
the weighted kappa value for intraobserver agreement
[47]
was 0.77 (95%CI: 0.66-0.87) . Validity assessment
was based on the correlations of BBPS scores with
relevant clinical outcomes and more traditional scale
categories, including “excellent”, “good”, “fair”, “poor”,
or “unsatisfactory”. Of the 633 patients who received a
CRC screening colonoscopy, 243 (38%) had at least one
polyp detected, and the PDR was significantly higher
for patients with BBPS scores ≥ 5 vs those for patients
with BBPS score < 5 (40% vs 24%, respectively; P <
0.02). The frequency of repeat colonoscopy attributable
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Exams given 10-yr follow-up interval (%)

100
90
80
70
60
50
40
30
20
10
0

0

n = 0/10

   1
   0/8

     2
    0/8

    3
      2/41

    4
       7/37

   5
47/89

   6
    7
    8
    9
  444/534      314/368     362/397    946/1024

Total Boston Bowel Preparation Scale Score

Figure 2 Percentage of screening colonoscopy examinations in which 10-year follow-up was recommended after a negative colonoscopy, stratified by
total Boston Bowel Preparation Scale Score[44].

Harefield Cleansing Scale

after washing or suctioning, and a separate fluid score
is included as a secondary measure (not incorporated
into the total score as in the OBPS). The total and fluid
scoring categories were designed to measure both
the quality of visualization and the intraprocedural ef
fort required to clean the mucosa to attain adequate
visualization. These parameters were intended to help
clinicians assess the cleansing efficacy of different bowel
[52]
preparations . A CBPS validation study prospectively
compared the results of the CBPS with the OBPS,
the BBPS, and a theoretical, dichotomous scale that
simply defined “adequate cleansing” as ability to see
≥ 95% of the mucosa (after it was cleansed), with
“inadequacy” being defined as visibility in < 95% in 150
[52]
colonoscopies at a single center . In this study, kappa
coefficients for interrater agreement were higher for
the CBPS (0.624-0.702) than the OBPS (0.493-0.655)
and the BBPS (0.545-0.661), but these differences
were not significant. Kappa coefficients for the total
colon fluid scores for the CBPS and OBPS, and Pearson
correlations coefficients for interrater agreement, were
also similar. For the OBPS, scores from 8-10 were graded
inadequate; for the BBPS, a score of ≤ 4 was graded
inadequate; and for the CBPS, total scores ≤ 24 were
graded inadequate. No clinically relevant parameters
were assessed for validation in this study.

The HCS, developed in the 1990s, is scored by colon
[51]
segment, as are the OBPS and BBPS . Like the BBPS,
the HCS is also scored after washing and suctioning
are completed, and replaces qualitative terms (e.g.,
“excellent” or “good”) with direct descriptions of clean
[51]
sing quality correlated with score numbers (Table 1) .
Grading is performed in five colon segments and ranges
from 0-4 (higher numbers indicating better quality of
cleanse) for each. Although total scores are derived by
adding the separate segment scores, an “acceptable”
score is possible only when the mucosa is 100% visible
in all five colon segments. A validation study of the HCS
compared with the Aronchick scale in 337 colonoscopies
reviewed by four gastroenterologists found that there
was a high degree of Pearson correlation between the
two scales (r = 0.833), and the Spearman correlation
coefficient was -0.778 (correlation is negative because
improved cleanse quality is represented by different
[51]
directions in the HCS and Aronchick scale) . The ROC
curve analysis vs the Aronchick scale showed an area
under the curve of 0.945, and a sensitivity of 99% and
specificity of 83% at the optimum score cut-off point.
Interrater reliability analysis yielded an ICC of 0.457
(95%CI: 0.366-0.539). Cohen kappa scores for individual
segments between investigators showed slight-to-fair
agreement ranging from 0.15-0.27. Internal consistency
was acceptable, based on a Cronbach alpha coefficient of
0.81, and the test-retest reliability assessment showed
an overall kappa of 0.639. No analyses of correlations
with relevant clinical outcomes such as the ADR or
adherence to recall guidelines were performed, due to
insufficient patient population.

ADDITIONAL VALIDATED SCALE
COMPARISON DATA
The OBPS and the BBPS were compared in a study that
reviewed prospectively collected data from patients who
underwent CRC screening or surveillance colonoscopies
over a two-year period between August 2013 and July
[58]
2015 . Of the 655 colonoscopies, overall detection rates
for polyp, adenoma, right-side adenoma, and sessile
serrated adenoma (SSA) were 42.8%, 32.8%, 20.8%,
and 1.2%, respectively. A significant Pearson correlation
was observed between the two scales (P < 0.001).

Chicago Bowel Preparation Scale

Like the HCS, the CBPS was developed to address
perceived limitations in other commonly used bowel
[52]
preparation scales . The main features of the scale are
shown in Table 1. Scoring is performed both before and
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However, the ROC curves for the OBPS vs the BBPS
were not significantly different for the detection rates,
respectively, for polyps (0.550 vs 0.513), adenoma (0.544
vs 0.519), right-side adenoma (0.469 vs 0.516), and SSA
(0.712 vs 0.790). The investigators concluded that the
choice of either the OBPS or the BBPS may not strongly
affect the measurement of bowel preparation quality.

aration quality/visibility; however, it also incorporates the
[11,50]
presence of luminal fluid before suctioning
. The OBPS
validation data are largely dependent on correlations with
the Aronchick scale, which itself has limited validation
[50]
and may not correlate with ADR . The BBPS differs
in several key aspects from the Aronchick and OBPS
[47]
scales . To begin, it requires washing and suctioning to
[47]
be completed before the bowel preparation is graded .
The HCS requires rating only after completion of flushing
and suctioning, providing a score for the entire colon as
[51,52]
well as for individual segments
.

DISCUSSION
Quality scales

All currently available bowel preparation quality scales
are imperfect, have limitations, and are dependent upon
subjective descriptions of luminal contents expressed
as categories (“excellent”, “good”, etc.) or numbers,
depending on the scale utilized. A standard, fully vali
dated, and universally accepted scale for use in clinical
practice and trials has not yet been established. Among
the scales, the Aronchick scale is the most well-known
and widely used clinically and in clinical trials to date;
however, this scale rates cleanse quality of the colon as
a whole and provides no details regarding differences
between individual segments.

Grading scales validity and reliability

The reliability and validation data for BBPS is more ex
tensive compared with the Aronchick and OBPS scales
and include good supporting data correlating scores
with key clinical outcomes. These validation studies
have provided information to create a threshold for
adequate cleansing of a score of at least 2 in each of
[44,57]
three colon segments
. It should also be noted,
however, that one study found no significant difference
between the BBPS and OBPS regarding key indicators
of colonoscopy quality, such as the PDR and ADR, in
[58]
screening or surveillance colonoscopy . Concerning the
HCS and CBPS, each has reported acceptable reliability
data, although the CBPS validation study was based
[51,52]
on findings from only two raters
. While the HCS
validation assessment was the only one to provide testretest and internal consistency data for reliability, its
validity evaluation was based only on correlations with
[51]
the Aronchick scale . Although the CBPS was compared
with the OBPS and BBPS, no correlations of this scale
with key clinical outcomes, such as ADR and adherence
to screening and surveillance colonoscopy intervals, have
[52]
been reported . The CBPS has more specific definitions
and requires measurement of fluid suctioned (Table 1),
but the complexity may be challenging for the clinician
to assess correctly; thus, it may not easily translate to
clinical practice. Hence, the usefulness of these scales for
clinical practice or trials remains unclear.
Several unique, nonvalidated bowel preparation
scales have been developed for use in trials of agents
including oral sulfate solution (OSS) (Suprep®, Braintree
[59]
Laboratories, Braintree, MA, United States) , OSS
plus sulfate-free electrolyte lavage solution (Suclear®,
[60]
Braintree Laboratories, Braintree, MA, United States) ,
and polyethylene glycol electrolyte solution plus ascorbic
acid (MoviPrep®, Salix Pharmaceuticals, Bridgewater, NJ,
[59,61,62]
United States)
. The grading criteria used in these
study- and product-specific scales often differ greatly
from validated scales.
The substantial ramification of using nonvalidated
scales is illustrated by a post hoc analysis of data from
two sodium picosulfate and magnesium citrate (P/MC)
clinical trials. Investigators analyzed the data from the
studies after altering the definition of “adequate” in the
Aronchick scale, which had been used in the original
trials, to more closely resemble what has been used

Colon segments cleansing

Guidance is somewhat vague for clinicians regarding
grading of the entire colon when individual segments
are suboptimally cleansed. This issue may arise more
often in the proximal colon, which is harder to clean
than other segments and more likely to contain flat
[50,51]
lesions such as sessile serrated polyps/adenomas
.
Segment-specific bowel preparation quality scales, such
as the OBPS or BBPS, may provide a clearer distinction
between cleanse quality of the proximal colon compared
with other segments. Furthermore, establishing a mini
mum acceptable score for adequacy within each colon
segment, as has been done for the BBPS, is helpful in
determining overall colon cleansing adequacy. A BBPS
validation study provided information used to create an
“adequate cleansing” threshold score of at least 2 in each
of three colon segments.

Need for washing and suctioning

Grading before or after washing and suctioning is another
important factor which differs between scales. Many
clinicians are using the Aronchick scale incorrectly, as
they grade the bowel preparation as good or fair after
washing and suctioning. While scales that grade cleanse
quality after washing may correlate better with quality
measures such as ADR, or the likelihood of an alteration
in CRC screening follow-up recommendations, scales
that grade before washing can provide a better reflection
of a bowel preparation product’s efficacy independent of
the endoscopist. Similarly, the OBPS gives points based
on the total fluid in the colon, which leads to inaccurate
grading if using water immersion/exchange.
The OBPS entails scoring by colon segments, thus
accounting for variation by segment in bowel prep
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[55]

4

in some studies utilizing nonvalidated scales . With
this revised definition, > 98% of all P/MC patients were
considered responders, compared with 79%-87% using
the original OBPS and Aronchick scale categorization cri
teria. Multiple studies have used more than one validated
scale from among the Aronchick, OBPS, and BBPS scales
for assessment of bowel preparation quality, providing
[63-70]
additional comparative data
. Generally, the results
of these trials have been concordant in assessment of
bowel preparation quality, with similar mean total scores
being reported for overall quality, and similar comparative
assessments of different bowel preparations.
While scales for assessment of bowel preparation
quality for CRC screening colonoscopy have improved,
establishing a standard, validated scale is essential to
optimize CRC colonoscopy screening. The Boston bowel
preparation scale has several limitations, but appears
nonetheless to be the best available option, and is there
fore recommended as the current standard for use in
clinical practice. Given the importance preparation plays
in multiple colonoscopy quality measures, including
the need to repeat the procedure when cleansing is
inadequate, it may be advantageous for clinicians to
adopt one language to describe cleansing quality. The
continued use of multiple scales with varying criteria may
undermine the validity of study findings and the accuracy
of colonoscopy for CRC screening and surveillance.
For colonoscopy clinical trials, the use of different,
and sometimes nonvalidated, scales across studies is
one of many reasons comparisons between studies is
fraught with difficulties. By incorporating a standard,
validated grading scale, we may ensure that the findings
are generalizable and comparable with other studies and
facilitate progress in the development of future bowel
preparations. Future developments in bowel preparation
quality assessment are likely to involve establishment
of an improved “gold standard” and further refinement
of the accuracy of quality assessment. Continued im
provement of quality standards for CRC prevention,
further studies of ADR and withdrawal time, and recom
mended years of follow-up are also warranted.
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